Product Information
CLOMIPRAMINE 50 MG CAPSULE is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.2257 per EA under NDC 16571068403. Its NADAC has been published 280 times since Feb 17, 2021.
Strength
50 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571068403
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CLOMIPRAMINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA212285On Market Since
11/1/2020
Pharmacological Classes
Price Statistics
The NADAC for CLOMIPRAMINE 50 MG CAPSULE has been published 280 times since Feb 17, 2021, and over the history we have for it it has declined 88.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2257 per EA |
|---|---|
| All-time high | $2.0285 (Mar 10, 2021) |
| All-time low | $0.2016 (May 22, 2024) |
| 52-week high | $0.2915 |
| 52-week low | $0.2257 |
| Median price | $0.3364 |
| Average price | $0.5957 |
| Largest weekly change | -56.5% (Nov 23, 2022) |
| Weeks tracked | 280 |
| Tracking since | Feb 17, 2021 |
Generic Alternatives
The matcher finds 8 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 8 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CLOMIPRAMINE 50 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CLOMIPRAMINE 50 MG CAPSULE, manufactured by Rising Pharma Holdings Inc., is $0.2257 per EA (NDC 16571068403), effective Jun 24, 2026.
How has the price of CLOMIPRAMINE 50 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CLOMIPRAMINE 50 MG CAPSULE has declined 88.9%. It has been tracked across 280 weekly CMS publications since Feb 17, 2021.
What are the highest and lowest recorded NADAC prices for CLOMIPRAMINE 50 MG CAPSULE?
Since Feb 17, 2021, the NADAC for CLOMIPRAMINE 50 MG CAPSULE has ranged from a low of $0.2016 (May 22, 2024) to a high of $2.0285 (Mar 10, 2021), with a median of $0.3364 per EA.
Are there cheaper alternatives to CLOMIPRAMINE 50 MG CAPSULE?
8 NADAC-published products share the same active ingredient, strength, and dosage form as CLOMIPRAMINE 50 MG CAPSULE, but none are currently priced below it.
Who manufactures CLOMIPRAMINE 50 MG CAPSULE?
CLOMIPRAMINE 50 MG CAPSULE (NDC 16571068403) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification